HEALTH NEWS

Study Title:

Arabinogalactan Alleviates Lipopolysaccharide-Induced Intestinal Epithelial Barr

Study Abstract

Arabinogalactan Alleviates Lipopolysaccharide-Induced Intestinal Epithelial Barrier Damage through Adenosine Monophosphate-Activated Protein Kinase/Silent Information Regulator 1/Nuclear Factor Kappa-B Signaling Pathways in Caco-2 Cells. 

Study Information

Int J Mol Sci. 2023 Oct 19;24(20):15337. doi: 10.3390/ijms242015337. PMID: 37895018; PMCID: PMC10607795.

Full Study

https://pubmed.ncbi.nlm.nih.gov/37895018/
Monthly Sale

Super Sale Is Here!

20% off 1-9 supplements

25% off 10-14 supplements

30% off 15+ supplements